ADT (Standard of Care) clinical trials

Study Evaluating the Efficacy and Safety of Darolutamide and Stereotactic Dose Escalated Radiotherapy in Patients With Localized Prostate Cancer and High-risk Features of Relapse

This study is testing new ways to treat prostate cancer that is considered high-risk. It combines a new drug called darolutamide and a special type of radiation therapy with standard treatments to see if they can better stop the cancer from spreading.